These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9468505)

  • 21. Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide.
    Yahi N; Fantini J
    PLoS One; 2014; 9(8):e104751. PubMed ID: 25140899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical interactions of amyloid beta-peptide with lipid bilayers.
    Matsuzaki K
    Biochim Biophys Acta; 2007 Aug; 1768(8):1935-42. PubMed ID: 17382287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of a highly soluble Aβ
    LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS
    Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer's Disease Therapy.
    Azzaz F; Chahinian H; Yahi N; Fantini J; Di Scala C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides.
    Mohlake P; Whiteley CG
    Mol Neurobiol; 2010 Jun; 41(2-3):149-58. PubMed ID: 20224908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracking the mechanism of fibril assembly by simulated two-dimensional ultraviolet spectroscopy.
    Lam AR; Rodriguez JJ; Rojas A; Scheraga HA; Mukamel S
    J Phys Chem A; 2013 Jan; 117(2):342-50. PubMed ID: 23214934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
    Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
    Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assembly of N-terminal Alzheimer's β-amyloid and its inhibition.
    Prasanna G; Jing P
    Biochem Biophys Res Commun; 2021 Jan; 534():950-956. PubMed ID: 33143872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganglioside-mediated aggregation of amyloid β-proteins (Aβ): comparison between Aβ-(1-42) and Aβ-(1-40).
    Ogawa M; Tsukuda M; Yamaguchi T; Ikeda K; Okada T; Yano Y; Hoshino M; Matsuzaki K
    J Neurochem; 2011 Mar; 116(5):851-7. PubMed ID: 20831659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
    Hojati S; Ghahghaei A; Lagzian M
    J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganglioside Nanocluster-Targeting Peptidyl Inhibitor Prevents Amyloid β Fibril Formation on the Neuronal Membrane.
    Matsubara T; Nakai M; Nishihara M; Miyamoto E; Sato T
    ACS Chem Neurosci; 2022 Jul; 13(13):1868-1876. PubMed ID: 35729803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation.
    McDonough RT; Paranjape G; Gallazzi F; Nichols MR
    Arch Biochem Biophys; 2011 Oct; 514(1-2):27-32. PubMed ID: 21843498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide.
    Tabassum S; Sheikh AM; Yano S; Ikeue T; Handa M; Nagai A
    FEBS J; 2015 Feb; 282(3):463-76. PubMed ID: 25404240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sugar distributions on gangliosides guide the formation and stability of amyloid-β oligomers.
    Saha J; Ford BJ; Wang X; Boyd S; Morgan SE; Rangachari V
    Biophys Chem; 2023 Sep; 300():107073. PubMed ID: 37413816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
    McLaurin J; Franklin T; Chakrabartty A; Fraser PE
    J Mol Biol; 1998 Apr; 278(1):183-94. PubMed ID: 9571042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclization of Peptides Enhances the Inhibitory Activity against Ganglioside-Induced Aβ Fibril Formation.
    Miyamoto E; Sato T; Matsubara T
    ACS Chem Neurosci; 2023 Dec; 14(23):4199-4207. PubMed ID: 37971427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
    McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
    Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
    Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
    Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.